4.7 Article

INACTIVATION OF KUPFFER CELLS BY GADOLINIUM CHLORIDE PROTECTS MURINE LIVER FROM RADIATION-INDUCED APOPTOSIS

Journal

Publisher

ELSEVIER SCIENCE INC
DOI: 10.1016/j.ijrobp.2009.09.063

Keywords

GdCl3; Kupffer cells; radiation-induced liver toxicity

Funding

  1. National Nature Science Foundation of China [30770636]

Ask authors/readers for more resources

Purpose: To determine whether the inhibition of Kupffer cells before radiotherapy (RT) would protect hepatocytes from radiation-induced apoptosis. Materials and Methods: A single 30-Gy fraction was administered to the upper abdomen of Sprague-Dawley rats. The Kupffer cell inhibitor gadolinium chloride (GdCl3; 10 mg/kg body weight) was intravenously injected 24 h before RT. The rats were divided into four groups: group 1, sham RT plus saline (control group); group 2, sham RT plus GdCl3; group 3, RT plus saline; and group 4, KT plus GdCl3. Liver tissue was collected for measurement of apoptotic cytokine expression and evaluation of radiation-induced liver toxicity by analysis of liver enzyme activities, hepatocyte micronucleus formation, apoptosis, and histologic staining. Results: The expression of interleukin-1 beta, interleukin-6, and tumor necrosis factor-alpha was significantly attenuated in group 4 compared with group 3 at 2, 6, 24, and 48 h after injection (p<0.05). At early points after RT, the rats in group 4 exhibited significantly lower levels of liver enzyme activity, apoptotic response, and hepatocyte micronucleus formation compared with those in group 3. Conclusion: Selective inactivation of Kupffer cells with GdCl3 reduced radiation-induced cytokine production and protected the liver against acute radiation-induced damage. (C) 2010 Elsevier Inc.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Gastroenterology & Hepatology

Integration of glucose and cardiolipin anabolism confers radiation resistance of HCC

Yuan Fang, Yizhi Zhan, Yuwen Xie, Shisuo Du, Yuhan Chen, Zhaochong Zeng, Yaowei Zhang, Keli Chen, Yongjia Wang, Li Liang, Yi Ding, Dehua Wu

Summary: The study identified a link between radiation resistance and metabolic reprogramming in hepatocellular carcinoma (HCC). By targeting metabolic pathways, potential combination approaches for radiotherapy in HCC were suggested. Activation of glucose metabolism predicted poor response to radiotherapy in cancer patients.

HEPATOLOGY (2022)

Article Oncology

Radiation Therapy Promotes Hepatocellular Carcinoma Immune Cloaking via PD-L1 Upregulation Induced by cGAS-STING Activation

Shi-Suo Du, Gen-Wen Chen, Ping Yang, Yi-Xing Chen, Yong Hu, Qian-Qian Zhao, Yang Zhang, Rong Liu, Dan-Xue Zheng, Jian Zhou, Jia Fan, Zhao-Chong Zeng

Summary: This study identified an immune-cloaking mechanism induced by radiation therapy (RT) and revealed the crucial role of the cGAS-STING pathway in this process. RT increased the expression of PD-L1 in liver cancer cells, inhibiting the activity of T cells and protecting tumor cells from immune clearance. The study also found that RT enhanced the antitumor effect of PD-L1 axis blockade and increased immune cell infiltration.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2022)

Article Gastroenterology & Hepatology

CircTUBD1 Regulates Radiation-induced Liver Fibrosis Response via a circTUBD1/micro-203a-3p/Smad3 Positive Feedback Loop

Hao Niu, Li Zhang, Biao Wang, Guang-Cong Zhang, Juan Liu, Zhi-Feng Wu, Shi-Suo Du, Zhao-Chong Zeng

Summary: The study reveals the mechanism and role of circTUBD1 in radiation-induced liver fibrosis (RILF) through a circTUBD1/ micro-203a-3p/Smad3 positive feedback loop, providing a novel therapeutic strategy for relieving RILF progression.

JOURNAL OF CLINICAL AND TRANSLATIONAL HEPATOLOGY (2022)

Article Oncology

Corresponding author. E-mail address: zeng.zhaochong@zs-hospital.sh.cn (Z.-C. Zeng). 1

Qi-Qiao Wu, Yi-Xing Chen, Shi-Suo Du, Yong Hu, Ping Yang, Jing Sun, Xin-Yue Wang, Wei-Xun Wu, Shu-Min Zhang, Zhao-Chong Zeng

Summary: This study evaluates the impact of dosimetric parameters on intrahepatic outfield recurrence and distant metastasis-free survival in patients with hepatocellular carcinoma (HCC) treated with stereotactic body radiation therapy (SBRT). The results suggest that higher dose received by the normal liver is associated with better intrahepatic out-field recurrence-free survival rate.

TRANSLATIONAL ONCOLOGY (2022)

Article Gastroenterology & Hepatology

Gut microbiota modulate radiotherapy-associated antitumor immune responses against hepatocellular carcinoma Via STING signaling

Zongjuan Li, Yang Zhang, Weifeng Hong, Biao Wang, Yixing Chen, Ping Yang, Jian Zhou, Jia Fan, Zhaochong Zeng, Shisuo Du

Summary: This study investigates the role of the gut microbiome in regulating response to radiotherapy in hepatocellular carcinoma (HCC) patients. The study found that dysbiosis of the gut microbiome impairs the antitumor immune response and leads to variations in the effectiveness of radiotherapy. The cGAS-STING-IFN-I pathway was identified as a key mechanism in this process. The study proposes cyclic-di-AMP as a potential target for modulating response to radiotherapy in HCC patients.

GUT MICROBES (2022)

Article Oncology

Higher serum sPD-L1 levels after radiotherapy indicate poor outcome in hepatocellular carcinoma patients

Yang Zhang, Zongjuan Li, Yixing Chen, Ping Yang, Yong Hu, Zhaochong Zeng, Shisuo Du

Summary: This study validates the upregulation of PD-L1 in tumor tissues after radiotherapy (RT) and demonstrates that higher post-RT serum sPD-L1 is associated with poor prognosis in hepatocellular carcinoma (HCC) patients. Additionally, patients with higher rate of sPD-L1 increase after RT show better treatment response and longer survival.

TRANSLATIONAL ONCOLOGY (2022)

Article Oncology

Maternal embryonic leucine zipper kinase in tumor cells and tumor microenvironment: An emerging player and promising therapeutic opportunity

Bu-Fu Tang, Ruo-Chen Yan, Si-Wei Wang, Zhao -Chong Zeng, Shi-Suo Du

Summary: Maternal embryonic leucine zipper kinase (MELK) is a member of the AMPK protein family and is highly expressed in various cancers. It plays an important role in regulating tumor cell functions and the tumor microenvironment. Targeting MELK has shown promising results in anti-tumor therapy.

CANCER LETTERS (2023)

Article Cardiac & Cardiovascular Systems

Critical Role of the cGAS-STING Pathway in Doxorubicin-Induced Cardiotoxicity

Wei Luo, Xiaoyi Zou, Yidan Wang, Zheng Dong, Xinyu Weng, Zhiqiang Pei, Shuai Song, Yongchao Zhao, Zilun Wei, Rifeng Gao, Beijian Zhang, Liwei Liu, Peiyuan Bai, Jin Liu, Xiang Wang, Tingwen Gao, Yang Zhang, Xiaolei Sun, Hang Chen, Kai Hu, Shisuo Du, Aijun Sun, Junbo Ge

Summary: The cardiac EC cGAS-STING pathway plays a critical role in doxorubicin-induced cardiotoxicity by reducing NAD levels and causing mitochondrial dysfunction. Targeting this pathway could be a potential therapeutic strategy for preventing cardiotoxicity.

CIRCULATION RESEARCH (2023)

Article Oncology

Single High-Dose Irradiation-Induced iRhom2 Upregulation Promotes Macrophage Antitumor Activity Through cGAS/STING Signaling

Xiaomei Zhao, Biao Wang, Yuan Zhuang, Shisuo Du, Zhaochong Zeng

Summary: This study investigates the immunomodulatory effects of different dose-fractionation schedules and finds that a single high-dose radiation schedule has a stronger antitumor effect. The study also reveals the involvement of the cGAS/STING signaling pathway in the immunomodulatory effects of single high-dose radiation.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

Article Oncology

STING-Dependent Sensing of Self-DNA Driving Pyroptosis Contributes to Radiation-Induced Lung Injury

Yang Zhang, Zongjuan Li, Weifeng Hong, Shujung Hsu, Biao Wang, Zhaochong Zeng, Shisuo Du

Summary: This study found that the cGAS-STING pathway is significantly upregulated after radiation therapy and plays a crucial role in radiation-induced lung injury. The study also discovered the key roles of NLRP3 and pyroptosis in the inflammatory response induced by radiation therapy. Moreover, Pulmozyme was shown to potentially mitigate RILI by degrading dsDNA and inhibiting the cGAS-STING-NLRP3 signaling pathway.

INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2023)

Article Oncology

Comparison of long-term outcomes of stereotactic body radiotherapy (SBRT) via Helical tomotherapy for early-stage lung cancer with or without pathological proof

Shaonan Fan, Qi Zhang, Jingyao Chen, Gang Chen, Jiangyi Zhu, Tingting Li, Han Xiao, Shisuo Du, Zhaochong Zeng, Jian He

Summary: A comparative study on stereotactic body radiotherapy via helical tomotherapy (HT-SBRT) for early-stage lung cancer patients with or without a pathological diagnosis found that empirical SBRT is a safe and effective treatment option in a multidisciplinary setting when patients with suspicious solitary pulmonary nodules (SPNs) are unable or refuse to obtain a definitive pathological diagnosis.

RADIATION ONCOLOGY (2023)

Article Oncology

Early complete tumor response as a survival predictor in hepatocellular carcinoma patients receiving stereotactic body radiation therapy

Qi-Qiao Wu, Yi-Xing Chen, Shi-Suo Du, Yong Hu, Ping Yang, Zhao-Chong Zeng

Summary: This study evaluated the different response patterns after Stereotactic Body Radiation Therapy (SBRT) and their predictive value in local control and progression of hepatocellular carcinoma (HCC). The results showed that early complete tumor response within 6 months after radiotherapy predicted better intrahepatic outfield-free survival, distant metastasis-free survival, and overall survival outcomes. This finding is important for guiding decision making.

CLINICAL AND TRANSLATIONAL RADIATION ONCOLOGY (2023)

Article Gastroenterology & Hepatology

Stereotactic body radiotherapy combined with sintilimab in patients with recurrent or oligometastatic hepatocellular carcinoma: A phase II clinical trial

Yi-Xing Chen, Ping Yang, Shi-Suo Du, Yuan Zhuang, Cheng Huang, Yong Hu, Wen-Chao Zhu, Yi-Yi Yu, Tian-Shu Liu, Zhao-Chong Zeng

Summary: This study evaluated the efficacy of combining SBRT with sintilimab in the treatment of patients with recurrent or oligometastatic HCC. The results showed that the combination therapy was effective and well-tolerated.

WORLD JOURNAL OF GASTROENTEROLOGY (2023)

Article Oncology

Additional adjuvant radiotherapy improves survival at 1 year after surgical treatment for pancreatic cancer patients with T-4, N-2 disease, positive resection margin, and receiving adjuvant chemotherapy

Lili Wu, Yaolin Xu, Yuhong Zhou, Zhaochong Zeng, Yue Fan, Dansong Wang, Wenchuan Wu, Xi Guo, Minzhi Lv, Yuxiu Ouyang, Shisuo Du, Wenhui Lou

Summary: This retrospective study examined the role of adjuvant radiation therapy (RT) after radical resection of pancreatic ductal adenocarcinoma (PDAC) and found that it did not result in an overall survival (OS) benefit for all patients. However, a potential OS benefit was observed in the subgroup of patients with T4N2 disease or R1 resection who survived for more than 1 year after surgery.

FRONTIERS IN ONCOLOGY (2023)

Article Immunology

Molecular Characteristics of T Cell-Mediated Tumor Killing in Hepatocellular Carcinoma

Wei-feng Hong, Mou-yuan Liu, Li Liang, Yang Zhang, Zong-juan Li, Keqi Han, Shi-suo Du, Yan-jie Chen, Li-heng Ma

Summary: This study identified two subtypes of hepatocellular carcinoma based on the expression of genes related to T cell-mediated tumor killing (TTK). These subtypes showed differences in tumor microenvironment, metabolic properties, and genetic variation, and predicted the response to chemotherapy or immunotherapy and overall survival.

FRONTIERS IN IMMUNOLOGY (2022)

No Data Available